S&P 500
7,401.00
+0.91%
Dow Jones
49,665.70
+0.19%
Nasdaq 100
29,241.00
+2.43%
Russell 2000
2,860.88
+0.82%
FTSE 100
10,263.70
+0.48%
Nikkei 225
63,767.70
+2.68%

Health and Healthcare

Biotech: Vertex and VIVUS Draw Short Interest (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS)

Photo of Trey Thoelcke
By Trey Thoelcke Updated Published
Follow 24/7 Wall St. on Google
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Invalid Image
The short interest in biotech stocks is generally rising, judging by the short interest changes from August 15 settlement date versus the July 31 settlement date.

We have tracked the key short interest changes in the following biotech and emerging pharma companies: Alexion Pharmaceuticals Inc. (NASDAQ: ALXN), Amgen Inc. (NASDAQ: AMGN), Arena Pharmaceuticals Inc. (NASDAQ: ARNA), Biogen Idec Inc. (NASDAQ: BIIB), Celgene Corp. (NASDAQ: CELG), Dendreon Corp. (NASDAQ: DNDN), Gilead Sciences Inc. (NASDAQ: GILD), Illumina Inc. (NASDAQ: ILMN), Onyx Pharmaceuticals Inc. (NASDAQ: ONXX), Pharmacyclics Inc. (NASDAQ: PCYC), Regeneron Pharmaceuticals Inc. (NASDAQ: REGN), Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) and VIVUS Inc. (NASDAQ: VVUS). We also tracked the iShares Nasdaq Biotechnology (NASDAQ: IBB) against the group.

Alexion Pharmaceuticals Inc. (NASDAQ: ALXN) short interest fell 10.0% between July 31 and August 15 to 5.28 million shares, the smallest number of shares sold short since the mid May reading.

Amgen Inc. (NASDAQ: AMGN) short interest fell 5.8% to 11.85 million shares. The average daily volume was the lowest it has been this year.

Arena Pharmaceuticals Inc. (NASDAQ: ARNA) short interest rose 9.5% to 42.75 million shares. Days to cover has increased to 3.

Biogen Idec Inc. (NASDAQ: BIIB) short interest fell 8.4% to 2.24 million shares. The average daily volume was the lowest it has been this year.

Celgene Corp. (NASDAQ: CELG) short interest rose 1.5% to 6.40 million shares.

Dendreon Corp. (NASDAQ: DNDN) short interest rose 6.1% to 43.37 million shares. Short interest has been rising since the end of May, and days to cover is more than 8. Short interest is 28.8% of the float.

Gilead Sciences Inc. (NASDAQ: GILD) short interest rose 16.6% to 21.05 million shares, the greatest number of shares sold short so far this year.

Illumina Inc. (NASDAQ: ILMN) short interest rose 3.1% to 22.10 million shares. Days to cover is 25 and short interest is 18.3% of the float.

Onyx Pharmaceuticals Inc. (NASDAQ: ONXX) short interest fell 3.2% to 5.74 million shares. Short interest was 9.1% of the float.

Pharmacyclics Inc. (NASDAQ: PCYC) short interest rose 9.1% to 5.33 million shares. Days to cover rose from 5 at the July 31 reading to 7 by August 15. Short interest was 9.8% of the float.

Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) short interest rose 0.1% to 4.97 million shares. Days to cover rose from 4 at the July 31 reading to 7.

Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) short interest rose 21.8% to 6.39 million shares. After falling in the previous four periods, short interest has risen again.

VIVUS Inc. (NASDAQ: VVUS) short interest rose 18.5% to 16.44 million shares, the highest number of shares sold short since mid March. Short interest was 16.5% of the float.

To show how the sector has held up: the iShares Nasdaq Biotechnology (NASDAQ: IBB) ETF closed at $134.83 on the same date. Its current 52-week range is $87.67 to $138.75.

Trey Thoelcke

Photo of Trey Thoelcke
About the Author Trey Thoelcke →

Trey has been an editor and author at 24/7 Wall St. for more than a decade, where he has published thousands of articles analyzing corporate earnings, dividend stocks, short interest, insider buying, private equity, and market trends. His comprehensive coverage spans the full spectrum of financial markets, from blue-chip stalwarts to emerging growth companies.

Beyond 24/7 Wall St., Trey has created and edited financial content for Benzinga and AOL's BloggingStocks, contributing additional hundreds of articles to the investment community. He previously oversaw the 24/7 Climate Insights site, managing editorial operations and content strategy, and currently oversees and creates content for My Investing News.

Trey's editorial expertise extends across multiple publishing environments. He served as production editor at Dearborn Financial Publishing and development editor at Kaplan, where he helped shape financial education materials. Earlier in his career, he worked as a writer-producer at SVE. His freelance editing portfolio includes work for prestigious clients such as Sage Publications, Rand McNally, the Institute for Supply Management, the American Library Association, Eggplant Literary Productions, and Spiegel.

Outside of financial journalism, Trey writes fiction and has been an active member of the writing community for years, overseeing a long-running critique group and moderating workshop sessions at regional conventions. He lives with his family in an old house in the Midwest.

Continue Reading

Trey Thoelcke |

Short Interest in Biotech on the Rise (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

With a couple of exceptions, the short interest in biotech stocks is on the rise again, judging by the short…

Trey Thoelcke |

Short Interest in Biotech Wanes (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

The short interest in biotech stocks is generally falling, judging by the short interest changes from August 31 settlement date…

Trey Thoelcke |

Short Interest in Biotech Remains Mixed (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

ThinkstockWe have tracked the key short interest changes in the following biotech and emerging pharma companies: Alexion Pharmaceuticals Inc. (NASDAQ:…

Trey Thoelcke |

Short Interest in Biotech Is Mixed (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

We have tracked the key short interest changes in the following biotech and emerging pharma companies: Alexion Pharmaceuticals Inc. (NASDAQ:…

Trey Thoelcke |

Short Interest in Biotech Is Mixed (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

The short interest in biotech stocks is mixed, judging by the short interest changes between the September 14 and September…

Trey Thoelcke |

Biotech: Dendreon and Regeneron Draw Short Interest

The short interest data is out from the July 31 settlement date and, with a couple of notable exceptions, short…

Trey Thoelcke |

Short Sellers Shy Away From Biotechs

24/7 Wall St. has tracked the short interest in leading biotech and emerging pharmaceutical stocks. By and large, short sellers…

Trey Thoelcke |

Who Bucked the Short Interest Trend in Biotech Stocks?

Thinkstock24/7 Wall St. has tracked the short interest in leading biotech and emerging pharmaceutical stocks. Many biotech stocks pulled back…

Trey Thoelcke |

Short Sellers Find Renewed Interest in Biotech Stocks

After retreating from many leading biotech and emerging pharmaceutical stocks in the previous two periods, short sellers returned in early…

Top Gaining Stocks

Akamai
AKAM • Vol: 21,556,944
Micron Technology
MU • Vol: 65,135,624
Intel
INTC • Vol: 227,504,426
Monster Beverage
MNST • Vol: 15,284,847
Dell Technologies
DELL • Vol: 12,167,525

Top Losing Stocks

Mettler Toledo International
MTD • Vol: 539,266
Motorola Solutions
MSI • Vol: 3,101,643
Expedia
EXPE • Vol: 4,189,786
Coterra Energy
CTRA • Vol: 73,319,495
Fidelity National Information Services
FIS • Vol: 11,468,820